To observe potential genetic interactions between BRCA1/2 and ALDH2 in a real‐world setting, we set out to recruit cases of BRCA1 and BRCA2 mutation carriers from breast cancer centers in Japan, and we determined ALDH2 genotypes using the previously established Taqman PCR assay. Here, BRCA2 is linked to breast cancer.